doi: 10.1161/hs0102.101817
(Stroke. 2002;33:238.)
© 2002 American Heart Association, Inc.
Original Contributions |
Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy
The West Birmingham Atrial Fibrillation Project
From the University Department of Medicine (G.Y.H.L., S.K., M.J., A.M.) and Department of Haematology (D.B.), City Hospital, Birmingham, England.
Correspondence to Prof G.Y.H. Lip, University Department of Medicine, City Hospital, Birmingham B18 7QH, England. E-mail: g.y.h.lip{at}bham.ac.uk
Background and Purpose— We hypothesized that different ethnic groups would have different levels of knowledge and perceptions of atrial fibrillation (AF) and of their antithrombotic therapy. To investigate this further, we conducted a cross-sectional survey of patients with documented chronic AF who were attending the anticoagulation clinic in our city center teaching hospital, serving a multiethnic population.
Methods— We surveyed 119 patients (77 male; mean age 69±9 years [mean±SD]); of these, 39 were Indo-Asian (33%), 27 Afro-Caribbean (23%), and 53 white (44%).
Results— Only 63% of patients in the overall study cohort were aware of their cardiac condition, with Indo-Asians and Afro-Caribbeans significantly less aware of AF compared with the white patients (P<0.001). When questioned about the perception of the severity of the underlying condition, the majority (61%) felt that AF was "not serious." A large proportion were unaware that AF predisposed to thrombosis and stroke; among the ethnic groups, Indo-Asians appeared to be the least aware of the stroke and thromboembolic associations of AF. Only 52% in the whole cohort were aware of the reason(s) for commencing their warfarin, whereas the remainder began warfarin therapy simply because their "doctor told them to." Most patients in the whole cohort were aware of warfarin being used to prevent blood clots (65%) or stroke (66%), but Indo-Asians and Afro-Caribbeans were less so. Only 45% of the study cohort believed that there was some risk associated with warfarin therapy in the form of either "bleeding" or "poisoning." Only a minority of Indo-Asians and Afro-Caribbeans with AF felt that their doctor had given them enough information about their warfarin therapy, and many from these ethnic groups felt that they were careless about taking their warfarin.
Conclusions— In conclusion, many patients with AF possess very limited knowledge of AF as well as its consequences and therapy. In particular, our study has highlighted significant differences between different ethnic groups in terms of their knowledge of the risks, actions, and benefits of warfarin as well as of AF itself.
Editorial Comment
The West Birmingham Atrial Fibrillation Project
This article has been cited by other articles:
 |
|
 |
|
  D. J. Gladstone, E. Bui, J. Fang, A. Laupacis, M. P. Lindsay, J. V. Tu, F. L. Silver, and M. K. Kapral Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated Stroke, January 1, 2009; 40(1): 235 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kumar, C. Gordon, V. Toescu, C. D. Buckley, R. Horne, P. G. Nightingale, and K. Raza Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin Rheumatology, May 1, 2008; 47(5): 690 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Lane and G. Y. H. Lip Maintaining Therapeutic Anticoagulation: The Importance of Keeping "Within Range" Chest, May 1, 2007; 131(5): 1277 - 1279. [Full Text] [PDF]
|
|
|
|
|
|
C. van Walraven, N. Oake, P. S. Wells, and A. J. Forster Burden of Potentially Avoidable Anticoagulant-Associated Hemorrhagic and Thromobembolic Events in the Elderly Chest, May 1, 2007; 131(5): 1508 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nieuwlaat, A. Capucci, G. Y.H. Lip, S. B. Olsson, M. H. Prins, F. H. Nieman, J. Lopez-Sendon, P. E. Vardas, E. Aliot, M. Santini, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur. Heart J., December 2, 2006; 27(24): 3018 - 3026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kakar, D. Lane, and G. Y. H. Lip Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema. Chest, November 1, 2006; 130(5): 1296 - 1299. [Full Text] [PDF]
|
|
|
|
|
|
G. Y.H. Lip, D. Lane, C. Van Walraven, and R. G. Hart Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation Stroke, September 1, 2006; 37(9): 2294 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Choudhury and G Y H Lip How good is anticoagulation control in non-valvar atrial fibrillation? Observations on the elderly, ethnicity, patient perceptions, and understanding of AF thromboprophylaxis Heart, April 1, 2005; 91(4): 425 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Sosin, G. S. Bhatia, R. C. Davis, and G. Y.H. Lip Heart failure--the importance of ethnicity Eur J Heart Fail, December 1, 2004; 6(7): 831 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Y H Lip, H Khan, A Bhatnagar, N Brahmabhatt, P Crook, and M K Davies Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project Heart, September 1, 2004; 90(9): 1016 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Ezekowitz and R. H. Falk The Increasing Need for Anticoagulant Therapy to Prevent Stroke in Patients With Atrial Fibrillation Mayo Clin. Proc., July 1, 2004; 79(7): 904 - 913. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Nadar, N. Begum, B. Kaur, S. Sandhu, and G. Y H Lip Patients' understanding of anticoagulant therapy in a multiethnic population J R Soc Med, April 1, 2003; 96(4): 175 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Freestone, G. Y.H. Lip, P. A. Scott, and A. M. Pancioli Anticoagulation Uptake in Emergency Department Patients With Atrial Fibrillation Stroke, March 1, 2003; 34(3): 591 - 591. [Full Text]
|
|
|
|
|
|
A. Garcia, F. Marin, B. Sanchez, V. Roldan, P. Marco, G.Y.H. Lip, K.H. Tan, C. Lau, and E. Williams Diurnal Variation in the Intensity of Anticoagulation in Atrial Fibrillation Stroke, January 1, 2002; 33(1): 322 - 324. [Full Text] [PDF]
|
|